Hydroxyproline

Hydroxyproline

1. Identity and Chemical Characterization

Chemical Names and Formula

The primary physiological form is (2S,4R)-4-Hydroxyproline, also designated L-hydroxyproline, with the molecular formula C₅H₉O₃N. It is abbreviated in the scientific literature as Hyp or O (e.g., in the Protein Data Bank). Although proline and hydroxyproline are often referred to as amino acids, their technically correct classification is as imino acids, because they contain a secondary amino group (imine) within a pyrrolidine ring structure.

Hydroxyproline differs structurally from proline by the presence of a hydroxyl (–OH) group attached to the gamma (C-4) carbon atom. This hydroxyl group is crucial for the formation of hydrogen bonds, which are essential for the stability of collagen. Proline and, by extension, its hydroxylated derivative contain a side-chain pyrrolidine; this exceptional chemical structure provides conformational rigidity and bending character along the polypeptide main chain, influencing the secondary structure of proteins and polypeptides around a proline residue.

Two isomeric forms of hydroxyproline have been identified in collagen: trans-4-hydroxy-L-proline is found in type I and type III collagen, whereas higher amounts of trans-3-hydroxy-L-proline are found in type IV collagen.

Classification

Hydroxyproline is a distinctive non-proteinogenic amino acid that serves as a critical component in the structure of collagen. Unlike the 20 standard amino acids directly incorporated by the ribosome, hydroxyproline is formed through a post-translational modification in which proline residues within a protein chain are hydroxylated. It is one of several so-called nonessential amino acids; animals can synthesize it from glutamic acid and do not require dietary sources.

Discovery and Early History

In 1902, the chemist Hermann Emil Fischer first isolated hydroxyproline from hydrolyzed gelatin. In 1905, Hermann Leuchs synthesized a racemic mixture of 4-hydroxyproline. These milestones marked the beginning of formal scientific understanding of collagen's unusual amino acid composition.

Natural Sources

Hydroxyproline is formed upon hydrolysis of connective-tissue proteins such as collagen (about 14 percent by weight) and elastin, but rarely from other proteins. Proline and hydroxyproline are major amino acids in collagen proteins, which contain three chains of polypeptides and are major extracellular components in connective tissues, including skin, tendon, cartilage, vessels of the vascular system, and bone. Together, proline and hydroxyproline constitute one-third of all amino acids in the collagen proteins, which comprise approximately 30% of the body's total proteins.

Hydroxyproline is broadly present in nature as a major amino acid component of collagen and as one of the amino acids composing elastin, and can be prepared by acid hydrolysis of collagen derived from animals such as pig and cow. Dietary sources richest in hydroxyproline therefore include all collagen-containing animal tissues: skin, cartilage, tendons, ligaments, bones, and connective tissue cuts of meat. Gelatin — a protein made up mainly of glycine, proline, and hydroxyproline — is created by extracting collagen from animal bones.

Hydroxyproline is present in gelatin and collagen, not in plant-based samples, meaning plant- and animal-based samples can be distinguished based on hydroxyproline content alone. This makes hydroxyproline a reliable analytical signature molecule for animal-derived connective tissue ingredients.

Common Forms and Preparations

As a dietary supplement or ingredient, hydroxyproline is commercially available in several forms:

• Free amino acid (L-hydroxyproline): Trans-4-hydroxy-L-proline can be prepared using proline 4-hydroxylase isolated from the genus Amycolatopsis or genus Dactylosporangium.
• Hydrolyzed collagen (collagen hydrolysate / collagen peptides): The most widely consumed form, delivered as a powder or capsule. The peptide mixture, which contains an abundance of hydroxyproline, proline, and glycine, is absorbed dose-dependently following bolus oral delivery, with a series of di- and tripeptides peaking in the circulation within one hour after consumption in humans.
• Gelatin: A partially hydrolyzed form of collagen, used in food and pharmaceutical applications. Products made from hydrolyzed gelatin have a long history of use in food and medicine, and regulatory organizations typically consider these products to be safe food products.
• N-acyl derivatives: N-acyl derivatives of hydroxyproline, including those of various hydroxyproline stereoisomers, are used in cosmetic compositions.

---

2. Traditional and Historical Use

Pre-Scientific Traditions

The usage of gelatin dates back to the Middle Ages, where there are records of people boiling deer antlers and calves' feet to achieve a gelatinous texture. Through slow cooking, bones release collagen, gelatin, and amino acids such as glycine, proline, hydroxyproline, and cysteine — nutrients that have long been associated with the resilience of joints, the maintenance of skin health, the support of digestion, and the process of recovery. What is today understood in biochemical terms as the unwinding of collagen helices, the gelation of proteins, and the fragmentation into peptides was already recognised in practice by cooks of the distant past, who knew that a pot left long at the fire yielded a restorative broth.

Traditional recipes intentionally used collagen-rich tissues to produce broths that would set into a firm gel when cooled. Romans recognised the difference between a broth that remained liquid and one that became "glued together," and the jellied form was prized for banquets and for preservation.

Traditional Chinese Medicine

Donkey-hide gelatin (Asini Corii Colla, ACC) has been applied as an important food therapy product to optimize immune response, improve metabolic balance, and treat gynecological diseases for centuries, since it was first documented in Shennong Bencao Jing (from approximately 200 BCE to 200 CE). As an important food therapy product with Traditional Chinese Medicine (TCM) applications, this collagen-rich preparation has been used for thousands of years. Hydroxyproline, as a dominant structural component of such gelatin preparations, is thus among the active constituents delivered in this long-standing therapeutic tradition, even though it was not identified by name until the twentieth century.

In Traditional Chinese Medicine, bones and connective tissues are simmered for different durations depending on the desired therapeutic effect; a "short decoction" of 2–3 hours produces a light broth used for daily nourishment, where collagen is partly intact and gelatin dominates.

European and Western Traditions

In pre-industrial European households, gelatin was difficult to prepare and its presence at a household dinner was an immediate indication of wealth. It was prepared by boiling animal bones, often from carcasses left over from meat sources, in large kettles for multiple days with constant supervision. Collagen-rich preparations in the form of stocks, aspics, and consommés have been central to European culinary and convalescent traditions for centuries, used to support recovery from illness, strengthen joints, and improve skin complexion — goals now partly supported by modern biochemical investigation.

---

3. Key Constituents, Biochemistry, and Mechanisms of Action

Biosynthesis: Post-Translational Hydroxylation

Hydroxyproline is produced by hydroxylation of the amino acid proline by the enzyme prolyl 4-hydroxylase following protein synthesis, as a post-translational modification. The enzyme-catalyzed reaction takes place in the lumen of the endoplasmic reticulum. Proline hydroxylation requires ascorbic acid (vitamin C). In addition to the substrate, hydroxylation of peptidyl prolyl residues — catalyzed by prolyl hydroxylase of skin, skeletal muscle, and granulating wounds — requires molecular oxygen, ascorbate, Fe²⁺, and alpha-ketoglutarate.

The most obvious early effects of absence of ascorbic acid in humans arise from the resulting defect in hydroxylation of proline residues of collagen, with reduced stability of the collagen molecule, causing scurvy.

Role in Collagen Structure

The helical region of collagen comprises the repeat of Gly–X–Y, where proline can be in the X or Y position and hydroxyproline occurs only in the Y position. This modification is not merely decorative; it is critical for the proper folding of the three polypeptide chains into a stable triple-helical structure at body temperature. The hydroxyl group on hydroxyproline stabilizes the helix primarily through stereoelectronic effects. Normal secretion of procollagen molecules out of the cells requires a critical amount of trans-4-hydroxy-L-proline. Therefore, without hydroxyproline, no functional collagen fibers appear in the extracellular space.

Each collagen subunit has approximately 80–100 hydroxyproline residues, depending on the collagen type and animal species. Up to 40% of proline residues in collagen may be hydroxylated to hydroxyproline.

Catabolism

Considering that hydroxyproline cannot be re-incorporated into pro-collagen during translation, it must be catabolized following protein degradation. This catabolic process takes place mainly in the liver and, to some extent, in the kidneys. Considering the huge turnover of collagen, hydroxyproline catabolism is essential for body homeostasis.

Two possible pathways exist to break down free 4-hydroxyproline: the hydroxyproline dehydrogenase (PRODH2) pathway results in the production of glycine, glyoxylate, glycolate, and oxalate; the L-amino-acid oxidase pathway results in the production of pyrrole-2-carboxylate. A cascade of reactions leads to production of two deleterious intermediates — glyoxylate and hydrogen peroxide — which need to be immediately converted; as a result, the enzymes involved in hydroxyproline catabolism are located in specific compartments: mitochondria and peroxisomes.

About 80% of the free hydroxyproline derived from protein degradation is metabolized in the liver and never appears in the urine. Free hydroxyproline released into the circulation during collagen degradation cannot be reutilized for synthesis and is therefore filtered by the kidney. Although most of the amino acid is reabsorbed by the kidney and ultimately catabolized by the liver, the moiety of hydroxyproline present in the urine is strictly dependent on collagen turnover.

Metabolic Contributions

Hydroxyproline's conversion into glycine enhances the production of glutathione, DNA, heme, and protein. Furthermore, oxidation of hydroxyproline by hydroxyproline oxidase (OH-POX) plays an important role in cell antioxidative reactions, survival, and homeostasis. Free hydroxyproline is not reused for protein synthesis; it was previously thought to be degraded terminally to glyoxylate and pyruvate. Recent studies, however, suggest that hydroxyproline, like proline, can be recycled via a redox shuttle, and research into its participation in redox and metabolic regulation is only beginning.

Bioactive Dipeptides Derived from Hydroxyproline

A critical aspect of hydroxyproline's pharmacological relevance as a dietary supplement relates to the hydroxyproline-containing dipeptides and tripeptides generated during digestion of collagen hydrolysate. Prolyl-hydroxyproline (Pro-Hyp) is a major collagen peptide component that remains in human blood after the ingestion of collagen peptides. Pro-Hyp and other hydroxyproline-containing peptides are difficult to hydrolyze in vivo and can play important functions in target tissues.

Collagen-derived hydroxyproline-containing peptides show a variety of physiological activities: Pro-Hyp and alanine–hydroxyproline–glycine (Ala–Hyp–Gly) promote cell proliferation in dermal fibroblasts, whereas Pro-Hyp, Ala–Hyp–Gly, and leucine–hydroxyproline–glycine (Leu–Hyp–Gly) enhance collagen secretion in preosteoblast cells. Hydroxyproline–glycine (Hyp–Gly) promotes myogenic differentiation and myotube hypertrophy. Leu–Hyp–Gly shows strong angiotensin-converting enzyme inhibitory activity.

Pro-Hyp is one of the major constituents of collagen-derived dipeptides. Research has shown that Pro-Hyp promotes the differentiation of osteoblasts by increasing Runx2, osterix, and Col1α1 mRNA expression levels. In mouse tendon cells, the dipeptide Pro-Hyp exhibits pronounced effects, promoting differentiation and maturation of tendon cells with modulation of lineage-specific factors and inducing significant chemotactic activity in vitro. In addition, Pro-Hyp has profound effects on cell proliferation, with significantly upregulated extracellular signal-regulated kinase phosphorylation and extracellular matrix production, and increased type I collagen network organization.

---

4. Scientific Evidence by Area of Use

4.1 Skin Health and Anti-Aging

Evidence Summary

This is the area with the largest body of human clinical trial data for hydroxyproline-containing collagen peptide supplementation. Among anti-aging nutraceuticals, hydrolyzed collagen (HC) is the most popular and promising skin anti-aging supplement. Studies have indicated that alanine–hydroxyproline–glycine and serine–hydroxyproline–glycine can be detected in human blood 1 hour after the oral ingestion of HC and deposited on the skin.

A systematic review and meta-analysis published in 2023 pooled 26 randomized controlled trials (RCTs) involving 1,721 patients to assess the effects of hydrolyzed collagen supplementation on skin hydration and elasticity. The findings revealed that HC supplementation can improve skin hydration and elasticity.

A 2025 randomized, double-blind, placebo-controlled clinical study found that twelve weeks of oral bioactive collagen peptide (BCP) supplementation, followed by a 4-week washout, produced lasting improvements in skin hydration, firmness, and dermal structure. These effects are likely linked to the BCP's high hydroxyproline content and low molecular weight distribution, supporting its use in anti-aging skincare strategies.

An emerging line of research suggests potential effects beyond cosmetic skin parameters. Collagen supplementation has gained attention based on claims of beneficial effects on healthy aging; researchers have identified that the minimal required unit of ingested collagen consists of a proper ratio of three glycine to one proline to one hydroxyproline — a combination sufficient to increase motility-healthspan and lifespan in C. elegans, as well as collagen homeostasis in human fibroblasts in vitro. In a clinical observational trial (ISRCTN93189645), oral supplementation in humans demonstrated improved skin features within three months and a reduction in biological age by 1.4 years (p = 0.04) within 6 months. This latter study should be interpreted with caution, as it was observational and not a fully blinded RCT.

Mechanistic Basis

Pro-Hyp triggers the growth of p75NTR-positive fibroblasts cultured on collagen gel but not p75NTR-negative fibroblasts. Thus, Pro-Hyp is a low molecular weight growth-initiating factor for specific fibroblasts that are involved in the wound healing process. Not all sources of hydrolyzed collagen have the same efficacy — even at the same dose and duration of administration, some specific sources are more effective than others. Studies are required to determine the proper source and therapeutic duration against skin aging.

Evidence Strength

The overall evidence for skin hydration and elasticity is moderate to moderately strong, supported by multiple RCTs and a 2023 meta-analysis. However, heterogeneity between preparations, small sample sizes in individual trials, and variable study durations limit the strength of the conclusions. Patients' lifestyle habits were not included in analyses, and supplementation in patients with healthier lifestyle habits could have presented more evident results. Additional large clinical trials are needed.

4.2 Joint Health, Osteoarthritis, and Cartilage

Evidence Summary

The use of collagen hydrolysate in the treatment of bone diseases causing joint pain and affecting function and mobility of joints, such as osteoarthritis and osteoporosis, has been evaluated. According to clinical research, people with hip or knee osteoarthritis who take 10 g of pharmaceutical-grade collagen hydrolysate (PCH) daily report less pain, and their blood concentration of hydroxyproline increases.

The collagen peptide mixture, which contains an abundance of hydroxyproline, proline, and glycine, is absorbed dose-dependently following oral delivery. It is considered safe as an oral supplement and, when consumed daily, beneficial effects have been observed in bone and skin. Data suggest that collagen hydrolysate has chondrogenic effects in vitro, consistent with a growing consensus that collagen derivatives may be chondroprotective in osteoarthritis, and aligned with clinical evidence of symptom-relieving effects in human subjects suffering from knee joint pain.

Emerging data suggest that hydrolyzed collagen peptides may improve skin elasticity, joint function, and recovery after exercise, particularly when co-supplemented with vitamin C, silica, or resveratrol.

Pro-Hyp reportedly affects the proliferation of fibroblasts and regulates the differentiation of chondrocytes. Cell culture and in vitro studies thus support a mechanistic basis for cartilage-relevant effects, though translation to robust clinical outcomes requires further large-scale human trials.

Evidence Strength

The evidence for joint symptom relief with collagen hydrolysate (and thus its constituent hydroxyproline-containing peptides) is preliminary to moderate. Individual RCTs show positive results, but the field is limited by small sample sizes, heterogeneous preparations, and the difficulty of blinding in supplement trials. The specific contribution of hydroxyproline as opposed to other collagen amino acids (glycine, proline) is not fully disaggregated in the clinical literature.

4.3 Bone Health

Evidence Summary

Pro-Hyp is one of the major constituents of collagen-derived dipeptides, and research has reported that Pro-Hyp promotes the differentiation of osteoblasts by increasing Runx2, osterix, and Col1α1 mRNA expression levels. The addition of Pro-Hyp increased alkaline phosphatase (ALP) activity in osteoblastic cell models, and an enhancing effect of Pro-Hyp on the Runx2 and osterix expression levels was observed in relevant experimental conditions. These are cell-culture findings.

Collagen hydrolysate is used in the pharmaceutical development of antioxidant supplements often combined with hyaluronic acid and vitamin C. It has an excellent therapeutic effect on osteoporosis and osteoarthritis, where a daily dose of 12 g enhances pain symptoms and contributes to bone health. It also increases mineral density and protects articular cartilage. This represents a summary of clinical studies as reported in a comprehensive review.

Evidence Strength

Evidence for direct hydroxyproline effects on bone density and structure in humans is preliminary. The osteoblast differentiation data are from cell culture studies. Clinical data on bone endpoints are largely derived from collagen hydrolysate supplementation studies that do not isolate the contribution of hydroxyproline specifically.

4.4 Wound Healing

Evidence Summary

Pro-Hyp is supplied to tissues by oral administration of gelatin or collagen hydrolysate. Supplementation of gelatin or collagen hydrolysate thus has therapeutic potential for chronic wounds. Animal studies and human clinical trials have demonstrated that the ingestion of gelatin or collagen hydrolysate enhances the healing of pressure ulcers in animals and humans and improves delayed wound healing in diabetic animals. Therefore, the low molecular weight fibroblast growth-initiating factor Pro-Hyp plays a significant role in wound healing and has therapeutic potential for chronic wounds.

Pro-Hyp is generated by the degradation of endogenous collagen in granulation tissue to activate cells involved in tissue reconstruction and remodeling. The administration of gelatin hydrolysate produces a significant increase in the mean diameter of collagen fibrils in the Achilles tendon in animal studies.

Evidence Strength

Evidence is preliminary to moderate. Human clinical trial data on wound healing with collagen hydrolysate exist but are limited in number and scale. The mechanistic pathway through Pro-Hyp and fibroblast activation is biologically plausible and partly supported by cell culture experiments. Larger, well-controlled clinical trials are required.

4.5 Hydroxyproline as a Biomarker of Collagen Turnover

Apart from its role as a supplement ingredient, hydroxyproline has an established clinical use as a laboratory biomarker of collagen metabolism. Hydroxyproline, being an amino acid largely restricted to collagen, is excreted in urine. Its excretion rate is known to be increased in certain conditions, notably Paget's disease — a metabolic bone disorder in which bone turnover is greatly increased. For this reason, urinary hydroxyproline has been used extensively as an amino acid marker for collagen degradation.

In situations where there are very high rates of bone turnover, such as in Paget's disease of bone, urinary hydroxyproline provides an adequate bone marker because a large proportion of urinary hydroxyproline is derived from bone collagen. The lack of specificity for this marker arises for more subtle changes in resorption rates, and it has been estimated that only about 50% of urinary hydroxyproline is normally derived from bone resorption.

Similar to other bone turnover markers, age- and sex-related changes in urinary hydroxyproline occur throughout life. The urine marker is higher in developing children than in adults, reaching a peak around pubertal age and decreasing thereafter. A postmenopausal increase of total hydroxyproline also occurs.

Until the early 1990s, urinary hydroxyproline was one of the main bone resorption markers available, but this assay lacked specificity and sensitivity. Today, serum hydroxyproline is considered a nonspecific marker of bone turnover. A major practical drawback of urinary hydroxyproline was the necessity for dietary restrictions on gelatin intake before applying the test. More specific newer markers, such as pyridinium cross-links, have largely replaced urinary hydroxyproline as a first-line bone resorption marker in clinical practice.

Hydroxyproline correlates with increased collagen anabolism or catabolism associated with pathological conditions such as Paget's disease, Marfan's syndrome, osteogenesis imperfecta, neoplastic growth in collagen tissues, and in various forms of dwarfism.

Increased serum and urine levels of hydroxyproline have also been demonstrated in Paget's disease.

4.6 Muscle and Tendon

Even without exercise, collagen peptide intake increased glycine, proline, and hydroxyproline levels in blood plasma and increased muscle connective protein synthesis rates in young men in a randomized, double-blinded, parallel-designed clinical study. In mouse tendon cell models, the dipeptide Pro-Hyp promotes differentiation and maturation of tendon cells, induces significant chemotactic activity, and has profound effects on cell proliferation with significantly upregulated ERK phosphorylation and extracellular matrix production. These findings suggest a potential role in tendon and connective tissue repair, but robust human RCT evidence specific to tendon outcomes for hydroxyproline is currently lacking.

---

5. Body Systems and Health Areas

Based on the current scientific literature, hydroxyproline is associated with the following body systems and health domains:

• Connective tissue system: Hydroxyproline is a major structural component of the extracellular matrix in connective tissues including skin, tendon, cartilage, vascular walls, and bone.
• Musculoskeletal system: Roles in joint cartilage integrity, bone matrix structure, tendon organization, and muscle connective tissue, mediated via collagen cross-linking and Pro-Hyp signaling.
• Integumentary system (skin): Skin health and appearance depend primarily on the quantity and quality of dermal collagen, which constitutes 70–80% of dermal dry weight and whose integrity directly determines skin elasticity, firmness, and moisture-holding capacity. Hydroxyproline is essential to collagen stability in the dermis.
• Hepatorenal system: The catabolism of hydroxyproline takes place mainly in the liver and kidneys, making these organs central to hydroxyproline homeostasis.
• Antioxidant defense: Hydroxyproline's conversion into glycine contributes to glutathione production, and oxidation by hydroxyproline oxidase plays an important role in cellular antioxidative reactions and homeostasis.
• Vascular system: Hydroxyproline is a structural component of vascular collagen; patients with complement activation have high turnovers of C1q, which contains 5% hydroxyproline by amino acid residue composition.
• Wound healing: Hydroxyproline-containing dipeptides, particularly Pro-Hyp, serve as local signaling molecules during tissue repair and remodeling.

---

6. Dosage Forms and Reported Doses

Hydroxyproline as a standalone ingredient is available as a free amino acid powder and capsule. More commonly, it is delivered as a component of collagen hydrolysate preparations. The following doses are as reported in the cited scientific literature:

• Collagen hydrolysate for joint pain (osteoarthritis, hip or knee): Clinical research has evaluated 10 g of pharmaceutical-grade collagen hydrolysate (PCH) daily, with subjects reporting reduced pain and increased blood hydroxyproline concentration.
• Collagen hydrolysate for bone and joint health (general): A daily dose of 12 g of hydrolyzed collagen has been reported to enhance pain symptoms and contribute to bone health, increasing mineral density and protecting articular cartilage.
• Skin anti-aging: In the systematic review and meta-analysis of 26 RCTs, the interventions used varied in dose and composition, reflecting significant heterogeneity across studies. Individual RCTs have commonly used doses ranging from approximately 2.5 g to 10 g of hydrolyzed collagen per day. The interventions used exhibited heterogeneity primarily because of the distinct measurement units and composition of the supplementation, and a number of included studies had fewer than 40 participants.
• Free L-hydroxyproline dietary supplementation in animal studies: In studies examining hydroxyproline's contribution to oxalate metabolism in primary hyperoxaluria mouse models, animals were fed diets containing 1% hydroxyproline.
• Stable isotope research doses (human pharmacokinetic study): In a controlled study designed to define hydroxyproline's metabolic contribution to oxalate synthesis, primed, continuous intravenous infusions of stable isotope [¹⁵N,¹³C₅]-hydroxyproline were performed in nine healthy subjects and 19 individuals with primary hyperoxaluria.

---

7. Safety Considerations and Interactions

General Safety

Products made from hydrolyzed gelatin — the principal delivery vehicle for hydroxyproline — have a long history of use in food and medicine, and regulatory organizations typically consider these products to be safe food products. Hydrolyzed collagen type I is considered safe as an oral supplement. Its clinical use is associated with minor side effects, mostly on the gastrointestinal tract, characterized by fullness or foul taste.

Oxalate Metabolism and Kidney Stone Risk

The most significant and evidence-supported safety concern specific to hydroxyproline relates to its metabolic conversion to oxalate. Hydroxyproline catabolism, which occurs mainly in the liver and kidney, is a prominent source of glyoxylate, and could account for a significant portion of the oxalate produced in primary hyperoxaluria (PH).

Endogenous synthesis of oxalate is an important contributor to calcium oxalate stone formation and renal impairment associated with primary hyperoxaluria. Although the principal precursor of oxalate is believed to be glyoxylate, pathways in humans resulting in glyoxylate synthesis are not well defined. Hydroxyproline, a component amino acid of collagen, is a potential glyoxylate precursor.

Endogenous oxalate metabolism occurs predominantly in the liver and is affected by dietary intake of precursors, including ascorbic acid and hydroxyproline. Dietary hydroxyproline, mainly present in collagen and gelatin, may also contribute to endogenous oxalate synthesis and urinary oxalate excretion in healthy subjects and in primary hyperoxaluria.

The major clinical manifestation of the Primary Hyperoxalurias is increased production of oxalate as a consequence of genetic mutations leading to aberrant glyoxylate and hydroxyproline metabolism. Hyperoxaluria can lead to the formation of calcium-oxalate kidney stones, nephrocalcinosis, and renal failure.

The metabolism of trans-4-hydroxy-L-proline, an amino acid derived predominantly from collagen metabolism, has been reported as a significant source of oxalate production in individuals with primary hyperoxaluria types 2 and 3 (PH2 and PH3).

Recent evidence suggests that hydroxyproline may play a role in primary hyperoxaluria. Sources of hydroxyproline include the diet and bone turnover. If hydroxyproline can be confirmed as a significant factor, dietary modification might be of value in reducing the severity of disease.

In the context of individuals with normal glyoxylate metabolism, the generation of glyoxylate from hydroxyproline is efficiently handled by liver peroxisomal enzymes, and the clinical relevance of dietary hydroxyproline to stone formation in healthy individuals requires further study. The concern is most directly applicable to persons with known primary hyperoxaluria (PH1, PH2, PH3) or recurrent calcium oxalate urolithiasis, in whom dietary restriction of collagen-rich foods may be a consideration.

Vitamin C Dependency

Proline hydroxylation — the reaction that produces hydroxyproline in collagen — requires ascorbic acid (vitamin C). The absence of ascorbic acid causes a defect in hydroxylation of proline residues of collagen, with reduced stability of the collagen molecule, causing scurvy. While this does not represent a safety interaction with supplemental hydroxyproline itself, it underscores the co-factor dependency relevant to endogenous collagen synthesis.

Rare Genetic Disorders: Hydroxyprolinemia

Hydroxyproline is produced by the post-translational modification of proline in collagen and a few other proteins by prolyl hydroxylase enzymes. Although this post-translational modification occurs in a limited number of proteins, its biological significance cannot be overestimated. Genetic disturbances in hydroxyproline catabolism — such as hydroxyprolinemia (deficiency of 4-hydroxyproline oxidase) — have been documented, though this is a rare inherited condition rather than a risk for the general population.

Interaction with Dietary Sources and Biomarker Interpretation

A major practical drawback of using urinary hydroxyproline as a clinical biomarker was the necessity for dietary restrictions on gelatin intake before applying the test, because ingested gelatin significantly raises urinary hydroxyproline, potentially confounding measurements of bone turnover. Individuals undergoing collagen supplementation should disclose this to clinicians ordering urinary hydroxyproline tests.

---

References

• Wu G et al. (2013). Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids. PMC3773366.
• Wikipedia. Hydroxyproline.
• Encyclopædia Britannica. Hydroxyproline.
• Summitt CB et al. (2022). Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment. PMC8779045.
• Pu SY et al. (2023). Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients. PMC10180699.
• Collagen peptide RCT (2025). The Sustained Effects of Bioactive Collagen Peptides on Skin Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study. PMC12661388.
• Kolovou et al. (2025). A collagen amino acid composition supplementation reduces biological age in humans and increases health and lifespan in vivo. npj Aging. PMC12635253.
• Shigemura Y et al. (2009). Effect of Prolyl-hydroxyproline (Pro-Hyp), a Food-Derived Collagen Peptide in Human Blood, on Growth of Fibroblasts from Mouse Skin. Journal of Agricultural and Food Chemistry.
• Sato K, Asai TT, Jimi S. (2020). Collagen-Derived Di-Peptide, Prolylhydroxyproline (Pro-Hyp): A New Low Molecular Weight Growth-Initiating Factor for Specific Fibroblasts Associated With Wound Healing. Frontiers in Cell and Developmental Biology. PMC7728856.
• Nomura K et al. (2017). Collagen-derived dipeptide prolyl-hydroxyproline promotes osteogenic differentiation through Foxg1. PMC5710072.
• Jafari L et al. (2021). The dipeptide prolyl-hydroxyproline promotes cellular homeostasis and lamellipodia-driven motility via active β1-integrin in adult tendon cells. PMC8239475.
• Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis. PMC5383229.
• ScienceDirect Topics. Hydroxyproline overview — bone turnover marker.
• Medscape. Bone Markers in Osteoporosis: Bone Turnover Markers.
• Knight J et al. (2012). Hydroxyproline metabolism in mouse models of primary hyperoxaluria. PMC3311317.
• Dindo M et al. (2018). Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria. PMC6054332.
• ScienceDirect. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
• Knight J et al. (2006). Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney International. PMID 17021603.
• Phang JM. (2020). Proline Metabolism and Microenvironmental Stress. PMC7365493.
• Wu G et al. (2018). Metabolism, Nutrition, and Redox Signaling of Hydroxyproline. Antioxidants & Redox Signaling.
• Natarajan SK et al. (2021). Proline metabolism and redox; maintaining a balance in health and disease. Amino Acids.
• Wu G et al. (2021). Hydroxyproline in animal metabolism, nutrition, and cell signaling. Amino Acids.
• Campos LD et al. (2024). Hydrolyzed collagen: Exploring its applications in the food and beverage industries and assessing its impact on human health. Heliyon.
• Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration. Frontiers in Nutrition 2025. PMC12739960.
• Virginia Tech Special Collections. More Than Just a Dessert: America's Gelatinous History — General History.
• Hou Y et al. (2021). Collagen derived species-specific peptides for distinguishing donkey-hide gelatin (Asini Corii Colla). Journal of Ethnopharmacology.
• ClinicalTrials.gov NCT02038543. Hydroxyproline Influence on Oxalate Metabolism.